Clario’s Andreas Kitzinger Receives 2021 MCC Champion Award

PHILADELPHIA – October 6, 2021 – ERT, the global clinical endpoint data collection leader, announced today that the Metrics Champion Consortium (MCC) named Andreas Kitzinger, Director of Quality Control and Process Implementation, as a 2021 MCC Champion. The MCC Champion Award recognizes select individuals who have made significant contributions to improving clinical trials’ efficiency, quality, and effectiveness.

Since 2010, Kitzinger has led ERT’s global customer success and quality teams. He brings over 15 years of experience in the life sciences industry and a commitment to improving clinical trial planning and execution, as well as developing integrated solutions to provide access to a broader team of medical and scientific industry leaders.

“It’s an honor to be recognized by the MCC alongside remarkable colleagues and leaders in the clinical trial industry,” said Kitzinger. “Looking ahead, I’m excited to continue improving and advancing how we serve customers and support clinical trial success by leveraging the science behind data capture and our integrated endpoint technology.”

Kitzinger joins MCC’s sixth class of MCC Champions Award recipients and will be featured in the October Issue of the MCC Metric Insights Newsletter.

Founded in 2006, MCC brings together clinical trial stakeholders from across the globe to collaboratively define standardized performance metrics that organizations can utilize to oversee and improve clinical trial planning and execution with the intent to drive process improvement.

About Clario

Clario delivers the leading endpoint technology solutions for clinical trials. Through experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals, Clario fuses scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device partners to transform lives. Clario has mastered the ability to generate rich evidence across all trial models: decentralized, hybrid and site-based clinical trials. With 30 facilities in nine countries across North America, Europe and Asia Pacific, Clario’s global team of science, technology and operational experts has been delivering the richest clinical evidence for nearly 50 years.